Aricept Approved to Treat Severe as Well as Milder Alzheimer’s Disease in China

Aricept Approved to Treat Severe as Well as Milder Alzheimer’s Disease in China
Aricept (donepezil hydrochloride) is now approved in China to treat patients with severe Alzheimer’s disease, as well as those with mild or moderate disease, Eisai recently announced. The extended approval was based on the results of a Phase 3 clinical trial (NCT01404169) conducted in that country. The study was designed to evaluate the efficacy and safety of Aricept

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *